novasterilis

This study evaluates #scCO2 for adipose tissue delipidation and decellularization. Results show preserved ECM proteins, growth factors, and enhanced cell–material interactions. This supports #scCO2’s use in bioactive coatings & soft tissue applications. bit.ly/493mpXi

#SterilizationValidation confirms process parameters achieve defined sterility assurance levels for each product. Method selection requires balancing microbial inactivation with material and functional constraints. Discover validation strategies: bit.ly/3TQ8QD0

Our new visualization capabilities allow us to observe #scCO2 flow dynamics, phase mixing, and the material’s response throughout the entire sterilization process. Take a look inside the #supercriticalCO2 vessel: bit.ly/4qZsI4H

#scCO2 offers low-temperature sterilization with deep penetration and no toxic residuals. Unlike #EtO, scCO2 sterilization can be utilized for liquid-based products such as hydrogels. Learn how scCO2 addresses the limitations of EtO: bit.ly/3p7NnIS

#AsepticManufacturing introduces significant constraints for sensitive devices. scCO2 provides the necessary terminal #sterilization at low temperatures while preserving biomaterials and functionality. Discover why manufacturers are making the shift: bit.ly/47jFBPD

The study implemented a one-pot #scCO2 process combining scaffold foaming and sterilization. Results demonstrate SAL 10-6 with preserved morphology and no cytotoxic residues. Dive into how #scCO2 has improved scaffold integrity and #sterilization: bit.ly/4sHXTS4

#scCO2 sterilization preserves collagen microarchitecture and growth factor activity in allografts. Clinical and preclinical data show comparable #ACLR outcomes and higher cytokine retention versus irradiation. Explore the study and methodology: bit.ly/4iFQFJ5

The NovaGenesis enables benchtop #scCO2 processing for research laboratories and beyond. Configurable vessel specifications and controls support precise, lab-scale #sterilization and development workflows. Learn more about the different models available: bit.ly/3Ow1SA6

NovaSterilis’ Therapeutics Sterilization Compatibility Guide has been updated with key new data! Updated entries highlight API and biologic compatibility under #supercriticalCO2 sterilization conditions. Download your NEW copy: bit.ly/45HI7ux

Contract e-beam #sterilization introduces recurring costs, shipping delays, and extended turnaround times. Cost modeling shows that in-house #scCO2 sterilization can actually reduce expenses by over 30%. Dive into this cost comparison study: bit.ly/4oj7nkj

This visualization compares material expansion under purge and no-purge #scCO2 conditions. Direct observation inside the chamber shows how process parameters influence material response. Learn more about our visualization capabilities: bit.ly/3KkJnz8

scCO2 sterilization is an effective modality for single-use and reusable medical devices. This study demonstrates that scCO2 and PAA is an effective terminal sterilization modality against resistant bacteria strains. Explore the findings: bit.ly/40fniXh

#SterilizationValidation confirms that defined process parameters achieve the required sterility assurance level. Selecting between overkill, bioburden, and combined BI/bioburden strategies requires balancing microbial control and material sensitivity. bit.ly/3TQ8QD0

Our #MaterialCompatibility Guide has been updated with several new additions! The latest updates expand compatibility data for materials exposed to #supercriticalCO2 sterilization. Download your updated copy here: bit.ly/3pueZIn

scCO2 can be a suitable terminal sterilization method for a variety of APIs, which can significantly reduce the effort required during production. This article dives into the growing trend in #MedicalDevice and #Pharmaceutical development. Read more: bit.ly/3P0Dl8S

#SupercriticalCO2 achieves a sterility assurance level of 10-6 across critical microorganisms. It effectively inactivates bacterial spores, viruses, yeast, and molds. This technology provides reliable, broad-spectrum #sterilization while maintaining product integrity.

#TissueBanks face increasing demands for terminal sterility without compromising graft performance. #SupercriticalCO2 achieves SAL 10-6 while preserving structural and biochemical properties. Dive into the accelerating adoption of supercritical CO2: bit.ly/4oNgN8s

Our #NovaGenesis VP-1000 equipment provides unprecedented insight into the #supercriticalCO2 process. Seeing inside the vessel reveals fluid dynamics, material interactions, and process behavior. Learn more about our new visualization capabilities: bit.ly/4qZsI4H

Contamination-driven experiment loss can increase cost and delay R&D timelines. #MaterialCompatibility testing verifies your material integrity and functional performance post-sterilization. bit.ly/4kjEnIt

Detergent-based #decellularization compromises ECM structure and bioactive signaling. This study evaluates a detergent-free scCO2-EtOH approach for heart dECM processing. Findings show that the method preserved structural proteins and angiogenic factors. bit.ly/3GZuL6X